Literature DB >> 16386870

Mechanism of toxicity of the branched-chain fatty acid phytanic acid, a marker of Refsum disease, in astrocytes involves mitochondrial impairment.

Georg Reiser1, Peter Schönfeld, Stefan Kahlert.   

Abstract

Phytanic acid is a saturated branched-chain fatty acid, which is formed by bacterial degradation of chlorophyll in the intestinal tract of ruminants. The methyl group in beta-position prevents degradation of phytanic acid by the beta-oxidation pathway. Therefore, degradation of phytanic acid is initiated by alpha-oxidation in peroxisomes. The inherited peroxisomal disorder Refsum disease is characterised by accumulation of phytanic acid. Unusually high concentrations of phytanic acid can be found in the plasma of Refsum disease patients, who suffer from neurodegeneration and muscle dystrophy. Phytanic acid has been suggested to be causally involved in the clinical symptoms. To elucidate the pathogenic mechanism, we investigated the influence of phytanic acid in rat hippocampal astrocytes by monitoring the cytosolic Ca(2+) concentration, the mitochondrial membrane potential (Deltapsi(m)), the generation of reactive oxygen species as well as the cellular ATP level. In response to phytanic acid (100 microM) cytosolic Ca(2+) was quickly increased. The phytanic acid-evoked Ca(2+) response was transient and involved activation of intracellular Ca(2+) stores. In isolated rat brain mitochondria, phytanic acid dissipated Deltapsi(m) in a reversible and dose-dependent manner. Moreover, phytanic acid released cytochrome c from mitochondria. Depending on the mitochondrial activity state, phytanic acid either stimulated or inhibited the electron flux within the respiratory chain. In addition, phytanic acid induced substantial generation of reactive oxygen species in isolated mitochondria as well as in intact cells. Phytanic acid caused cell death of astrocytes within a few hours of exposure. In conclusion, we suggest that phytanic acid initiates astrocyte cell death by activating the mitochondrial route of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16386870     DOI: 10.1016/j.ijdevneu.2005.11.002

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  18 in total

Review 1.  Hormetics: dietary triggers of an adaptive stress response.

Authors:  Marc Birringer
Journal:  Pharm Res       Date:  2011-08-05       Impact factor: 4.200

2.  Effects of Low Phytanic Acid-Concentrated DHA on Activated Microglial Cells: Comparison with a Standard Phytanic Acid-Concentrated DHA.

Authors:  María Belén Ruiz-Roso; Elena Olivares-Álvaro; José Carlos Quintela; Sandra Ballesteros; Juan F Espinosa-Parrilla; Baltasar Ruiz-Roso; Vicente Lahera; Natalia de Las Heras; Beatriz Martín-Fernández
Journal:  Neuromolecular Med       Date:  2018-05-30       Impact factor: 3.843

Review 3.  Neurodevelopmental manifestations of mitochondrial disease.

Authors:  Marni J Falk
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

4.  Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease.

Authors:  Mateus Grings; Anelise Miotti Tonin; Lisiane Aurélio Knebel; Angela Zanatta; Alana Pimentel Moura; Carlos Severo Dutra Filho; Moacir Wajner; Guilhian Leipnitz
Journal:  Mol Cell Biochem       Date:  2012-04-15       Impact factor: 3.396

5.  Refsum's Disease-Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder.

Authors:  Nimalie J Perera; Barry Lewis; Huy Tran; Michael Fietz; David R Sullivan
Journal:  J Obes       Date:  2010-09-01

6.  Marked inhibition of Na+, K(+)- ATPase activity and the respiratory chain by phytanic acid in cerebellum from young rats: possible underlying mechanisms of cerebellar ataxia in Refsum disease.

Authors:  Estela Natacha Brandt Busanello; Ângela Zanatta; Anelise Miotti Tonin; Carolina Maso Viegas; Carmen Regla Vargas; Guilhian Leipnitz; César Augusto João Ribeiro; Moacir Wajner
Journal:  J Bioenerg Biomembr       Date:  2012-11-15       Impact factor: 2.945

7.  Ataxia with loss of Purkinje cells in a mouse model for Refsum disease.

Authors:  Sacha Ferdinandusse; Anna W M Zomer; Jasper C Komen; Christina E van den Brink; Melissa Thanos; Frank P T Hamers; Ronald J A Wanders; Paul T van der Saag; Bwee Tien Poll-The; Pedro Brites
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-11       Impact factor: 11.205

Review 8.  Redox interplay between mitochondria and peroxisomes.

Authors:  Celien Lismont; Marcus Nordgren; Paul P Van Veldhoven; Marc Fransen
Journal:  Front Cell Dev Biol       Date:  2015-05-27

9.  Neurodegeneration in a Drosophila model of adrenoleukodystrophy: the roles of the Bubblegum and Double bubble acyl-CoA synthetases.

Authors:  Anna Sivachenko; Hannah B Gordon; Suzanne S Kimball; Erin J Gavin; Joshua L Bonkowsky; Anthea Letsou
Journal:  Dis Model Mech       Date:  2016-02-18       Impact factor: 5.758

Review 10.  Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked Adrenoleukodystrophy.

Authors:  Peter Schönfeld; Georg Reiser
Journal:  Aging Dis       Date:  2016-03-15       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.